Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort

Summary

This is an observational, retrospective, analytical, and multicenter study conducted at 17 hospitals. Our research aims to assess the effectiveness of Hemospray® in patients with gastrointestinal bleeding in clinical practice. Besides, we aim to detect predictors of treatment failure defined as unsuccessful immediate hemostasis or rebleeding.

Conditions

• Gastrointestinal Hemorrhage
• Ulcer Hemorrhage
• Tumor Bleeding

Interventions

DEVICE

Hemospray®

Hemospray® application

Sponsors & Collaborators

• University of Salamanca

  collaborator OTHER

• Hospital del Mar

  collaborator OTHER

• Puerta de Hierro University Hospital

  collaborator OTHER

• Complejo Hospitalario de Navarra

  collaborator OTHER

• Hospital de Henares

  collaborator OTHER

• Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

  collaborator OTHER

• Quirón Madrid University Hospital

  collaborator OTHER

• Hospital de Cruces

  collaborator OTHER

• Hospital General Universitario Gregorio Marañon

  collaborator OTHER

• Hospital Universitario Central de Asturias

  collaborator OTHER

• Hospital Universitario de Cabuenes

  collaborator OTHER

• Hospital Universitario Doctor Peset

  collaborator OTHER

• Hospital del Rio Hortega

  collaborator OTHER

• Hospital Universitario Madrid Sanchinarro

  collaborator OTHER

• Hospital de Aviles

  collaborator UNKNOWN

• Hospital IMQ Zorrozaurre

  collaborator UNKNOWN

• Hospital Universitario Ramon y Cajal

  lead OTHER

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-07-01

Primary Completion

2018-12-30

Completion

2018-12-30

FDA Device

Yes

Countries

• Spain

Study Locations